Journeys Metabolic is the first enterprise intervention platform that helps value-based organizations improve clinical and financial outcomes for metabolic disease.

Our HITRUST, EHR-interoperable platform supports population-wide reversal and prevention of metabolic disease via an automated provider workflow engaging qualified targeted patient populations, including those with type 2 diabetes, NAFLD, metabolic syndrome, and obesity. 

The core clinical component is a 4-month, physician developed, digital program that leverages personalized educational content delivery, computer vision for food tracking, and a proprietary metabolic biomarker device. 

Journeys Metabolic is the first enterprise intervention platform that helps value-based organizations improve clinical and financial outcomes for metabolic disease.

Our HITRUST, EHR-interoperable platform supports population-wide reversal and prevention of metabolic disease via an automated provider workflow engaging qualified targeted patient populations, including those with type 2 diabetes, NAFLD, metabolic syndrome, and obesity. The core clinical component is a 4-month, physician developed, digital program that leverages personalized educational content delivery, computer vision for food tracking, and a proprietary metabolic biomarker device. 

Rimidi’s cardiometabolic platform supports disease management of some of the most prevalent and costly chronic conditions. The platform provides access to the tools required to manage multiple disease states – Diabetes, Cardiovascular Disease/Hypertension, Heart Failure, Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH), and Obesity. The platform consolidates relevant clinical data from the EMR for each disease state with patient-generated health data from connected devices or surveys, and layers clinical decision support that can be mapped against national or practice guidelines. Our cardiometabolic snapshot allows clinicians to quickly assess patient status for each comorbid disease state -- are screenings up to date? Are key metrics well-controlled?

The Journeys Metabolic HI-TRUST, EHR-interoperable platform enables clinical and financial decision-makers, including care management teams, to standardize metabolic care for their population health initiatives via an automated provider workflow engaging qualified, targeted patient populations.

Journeys Metabolic is an interoperable, non-prescription behavior modification platform built for VBO's as the first standardized disease reversal and prevention enablement solution in primary care.

Other digital program platforms are non-integrated, disease management point solutions.  

In the sales process, we often hear “Doesn’t Epic (or other EHR) do that?” Rimidi is not built to replace the EHR, but to enhance it by bringing in additional data sets, providing more efficient workflows, and improving the user experience. Rimidi can install and configure its platform within 3-6 weeks which is significantly faster and more cost effective than onsite EHR teams can build and support enhancements to meet clinical needs. Rimidi’s modern technology stack enables rapid cycle innovation and iteration post-go live.

Rimidi’s cardiometabolic platform is most often compared to other Remote Patient Monitoring solutions, but the platform-approach to RPM allows Rimidi to do so much more. Some key differentiators of the Rimidi platform are: (1) tight integration with leading EHRs via SMART on FHIR, (2) the breadth of the comorbid disease states we cover, (3) our incorporations of patient-reported outcomes and social determinants of health measures and (4) our Clinical Decision Support engine. Rimidi’s CDS cards support almost any insight or intervention a client wants: RPM data alerting and interventions, referral management, lab or medication recommendations, clinical trial identification, and more.